Common Stock, Shares, Outstanding of Enveric Biosciences, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Enveric Biosciences, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Enveric Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 518,296, a 94% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Enveric Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 518,296 -8,476,624 -94% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 3,026,028 -4,852,540 -62% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 2,471,656 -4,822,349 -66% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 56,501 -126,124 -69% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 8,994,920 +6,813,008 +312% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 7,878,568 +5,736,786 +268% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 7,294,005 +5,215,734 +251% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 182,625 -1,895,646 -91% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 2,181,912 +103,641 +5% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 2,141,782 +1,087,739 +103% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 2,078,271 -50,545,136 -96% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 2,078,271 +1,426,350 +219% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 2,078,271 -29,305,361 -93% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 1,054,043 -20,378,372 -95% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 52,623,407 +33,173,432 +171% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 651,921 -9,443,188 -94% 31 Dec 2021 10-K/A 09 Jun 2023 2022 FY
Q3 2021 31,383,632 +25,646,631 +447% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 21,432,415 +16,269,150 +315% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 19,449,975 +16,203,270 +499% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 10,095,109 +4,783,695 +90% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 5,737,001 -57,083,788 -91% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 5,163,265 -47,254,423 -90% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 3,246,705 -47,070,983 -94% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 5,311,414 +3,618,249 +214% 31 Dec 2019 10-K 01 Apr 2021 2020 FY
Q3 2019 62,820,789 +39,874,772 +174% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 52,417,688 +33,405,241 +176% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 50,317,688 +31,526,690 +168% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 1,693,165 -16,469,558 -91% 31 Dec 2018 10-K/A 12 Aug 2020 2019 FY
Q3 2018 22,946,017 +7,089,768 +45% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 19,012,447 +4,362,035 +30% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 18,790,998 +4,211,581 +29% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 18,162,723 +4,276,751 +31% 31 Dec 2017 10-K 26 Mar 2019 2018 FY
Q3 2017 15,856,249 +2,370,777 +18% 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 14,650,412 +1,164,940 +8.6% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 14,579,417 +2,705,056 +23% 31 Mar 2017 10-Q/A 15 May 2017 2017 Q1
Q4 2016 13,885,972 +2,011,611 +17% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 13,485,472 +1,846,406 +16% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 13,485,472 +1,846,406 +16% 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 11,874,361 +1,881,533 +19% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 11,874,361 -3,535,638 -23% 31 Dec 2015 10-K/A 04 Apr 2017 2016 FY
Q3 2015 11,639,066 -3,770,933 -24% 30 Sep 2015 10-Q 23 Nov 2015 2016 Q2
Q2 2015 11,639,066 -3,770,933 -24% 30 Jun 2015 10-Q 18 Aug 2015 2015 Q1
Q1 2015 9,992,828 +3,395,497 +51% 31 Mar 2015 10-KT 15 Mar 2016 2015 T3
Q4 2014 15,409,999 +3,267,974 +27% 31 Dec 2014 10-Q 14 May 2015 2015 Q1
Q3 2014 15,409,999 +3,267,999 +27% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 15,409,999 +3,267,999 +27% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 6,597,331 -5,544,669 -46% 31 Mar 2014 10-KT 15 Mar 2016 2015 T3
Q4 2013 12,142,025 0 0% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q3 2013 12,142,000 0 0% 30 Sep 2013 10-Q 06 Nov 2013 2013 Q3
Q2 2013 12,142,000 0 0% 30 Jun 2013 10-Q 01 Aug 2013 2013 Q2
Q1 2013 12,142,000 0 0% 31 Mar 2013 10-Q 02 May 2013 2013 Q1
Q4 2012 12,142,025 +25 0% 31 Dec 2012 10-K 28 Mar 2014 2013 FY
Q3 2012 12,142,000 0 0% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 12,142,000 +5,642,000 +87% 30 Jun 2012 10-Q 01 Aug 2012 2012 Q2
Q1 2012 12,142,000 31 Mar 2012 10-Q/A 10 May 2012 2012 Q1
Q4 2011 12,142,000 +5,642,000 +87% 31 Dec 2011 10-K 28 Feb 2013 2012 FY
Q3 2011 12,142,000 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 6,500,000 30 Jun 2011 10-Q 02 Aug 2011 2011 Q2
Q4 2010 6,500,000 31 Dec 2010 10-K 07 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.